Leading Provider of Personalized
and Bio-Analytics Solutions

Including personalized cancer testing, in vitro cell-based testing technologies and image analytics software. 

Invitrocue - Leader in Personal Oncology Testing
Invitrocue - Leader in Personal Oncology Testing

How can
we address your interest?

Invitrocue - Patient, Health Care Provider

Patient / Physician /
Health Care Provider

Your cancer is so different and unique as you are. But treatments today are still mostly one-size-fits-all.

Invitrocue - Leader in Personal Oncology Testing

Scientist / Researcher

We focus on developing in vitro & in vivo models for safety and efficacy testing. Find out what services best meets your R&D needs.

Invitrocue - Leader in Personal Oncology Testing


Invitrocue recognizes the value of providing current and relevant information to its shareholders and potential investors. 

Leader in Personalized
Oncology Testing

Invitrocue has developed a unique 3D cell-based scaffolding technology that mimics human organ samples for using in the field of infectious diseases.

In 2016, the company expanded its work in liver disease to the field of oncology. The technology enables patient-derived cancer cells (organoids) to be cultured in laboratories for testing against a panel of drugs to support clinical decision making for individual patients (personalized oncology testing).  

Invitrocue - Leader in Personal Oncology Testing


Personalizing Your Treatment

Everyone's cancer is different, but treatments today are mostly "one-size-fits-all".

Onco-PDO™ is a test, result of a first-of-its-kind partnership between Invitrocue and A*STAR’s Genome Institute of Singapore, a world-leading research institution in the field of personalized oncology.

The test uses your own cancer cells to identify the most effective treatment options by growing them in the laboratory and testing them against a panel of approved chemotherapy drugs. From there, we can determine which drugs are more likely to be effective against your particular cancer.  

Onco-PDO Report


Explore the services that Invitrocue has to offer.

Invitrocue - Services
Invitrocue - Contact Us

Are you interested in Invitrocue?
Get in touch with our team.

All enquiries are welcomed. We look forward to hearing from you!

Latest press
and news

Annals of Oncology – ESMO Abstract 233P

Link to PDF (annalsofoncology.org) 233P – Breast Cancer Organoids Mimic Disease Heterogeneity, Allow High-Throughput Drug Screening and Show Correlation with Clinical Response Abstract 233P Background Breast